Most Helicobacter pylori-infected patients have specific antibodies, and some also have H. pylori antigens and genomic material in bile: Is it a risk factor for gallstone formation?

Digestive Diseases and Sciences

Volumn 43, Issue 4, 1998, Pages 854-862

  Figura, N ^a   Cetta, F ^b   Angelico, M ^b   Montalto, G ^b   Cetta, D ^b   Pacenti, L ^b   Vindigni, C ^b   Vaira, D ^b   Festuccia, F ^b   De Santis, A ^b   Rattan, G ^b   Giannace, R ^b   Campagna, S ^b   Gennari, C ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b NONE

Author keywords

Bile samples; CagA; Gallstones; Helicobacter pylori; Polymerase chain reaction; Western blotting

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; CHOLESTEROL; MICROSOMAL AMINOPEPTIDASE;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; BILE; CONTROLLED STUDY; FEMALE; GALLSTONE FORMATION; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEQUENCE HOMOLOGY;

ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; ANTIGENS, CD13; BACTERIAL PROTEINS; BILE; CASE-CONTROL STUDIES; CHOLELITHIASIS; FEMALE; GENES, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 15144351064     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018838719590     Document Type: Article

References (41)

1. Blaser MJ: Hypothesis on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 102:720-727, 1992
2. Crabtree JE: Gastric mucosal inflammatory responses to Helicobacter pylori. Aliment Pharmacol Ther 10(suppl 1):29-37, 1996
3. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127-1131, 1991
4. Parsonnet J: Helicobacter pylori and gastric cancer. Gastroenterol Clin North Am 22:89-104, 1993
5. Wotherspoon AC, Ortiz Hidalgo C, Falzon MR, Isaacson PG: Helicobacter pylori-associated gastritis and primary B-cell gastric carcinoma. Lancet 338:1175-1176, 1991
6. Owen RJ, Figura N, Moreno M: Biotypes and DNA fingerprints of cytotoxigenic Helicobacter pylori from patients with gastritis and peptic ulceration in Italy. Eur J Epidemiol 8:15-21, 1992
7. Telford JL, Ghiara P, Dell'Orco M, Comanducci M, Burroni D, Bugnoli M, Tecce MF, Censini S, Covacci A, Xiang Z, Papini E, Montecucco C, Parente L, Rappuoli R: Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 179:1653-1658, 1994
8. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, Massone A, Papini E, Xiang Z, Figura N, Rappuoli R: Molecular Characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 90:5791-5795, 1993
9. Xiang Z, Censini S, Bayeli PF, Telford JL, Figura N, Rappuoli R, Covacci A: Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that the clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating toxin. Infect Immun 63:94-98, 1995
10. Figura N, Guglielmetti P, Rossolini A, Barberi A, Cusi MG, Musmanno RA, Russi M, Quaranta S: Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcer and from patients with chronic gastritis only. J Clin Microbiol 27:225-226, 1989
11. Cover TL, Cao P, Murthy UK, Sipple MS, Blaser MJ: Serum neutralizing antibody response to the vacuolating cytotoxin of Helicobacter pylori. J Clin Invest 90:913-918, 1992
12. Goossens H, Glupczynski Y, Burette A, Lambert J-P, Vlaes L, Butzler J-P: Role of the vacuolating toxin from Helicobacter pylori in the pathogenesis of duodenal and gastric ulcer. Med Microbiol Lett 1:153-159, 1992
13. Rautelin H, Blomberg B, Fredlund H, Järnerot G, Danielsson D: Incidence of Helicobacter pylori strains activating neutrophils in patients with peptic ulcer disease. Gut 34:599-603, 1993
14. Phadnis SH, Ilver D, Janzon L, Normark S, Westblom TU: Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori. Infect Immun 62:1557-1565, 1994
15. Housson M-O, Gottrand F, Vachee A, Dhaenens L, Martin de la Salle E, Turck D, Houcke M, Leclerc H: Importance in diagnosis of gastritis of detection by PCR of the cagA gene in Helicobacter pylori strains isolated from children. J Clin Microbiol 33:3300-3303, 1995
16. Oderda G, Figura N, Bayeli PF, Basagni C, Bugnoli M, Armellini D, Altare F, Ansaldi N: Serologic IgG recognition of Helicobacter pylori cytotoxin-associated protein, peptic ulcer and gastroduodenal pathology in childhood. Eur J Gastroenterol Hepatol 5:695-699, 1993
17. Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS, Rathbone BJ: Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 338:332-335, 1991
18. Tebbe B, Geilen CC, Schulzke J-D, Bojarski C, Radenhausen M, Orfanos CE: Helicobacter pylori infection and chronic urticaria. J Am Acad Dermatol 34:685-686, 1996
19. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm J, Northfield TC: Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71:437-439, 1994
20. Patel P, Mendall MA, Khulusi S, Strachan DP: Helicobacter pylori infection in childhood: Risk factors and effect on growth. Br Med J 309:1119-1123, 1994
21. Offner GD, Gong D, Afdhal NH: Identification of a 130-kilodalton human biliary concavalin A binding protein as aminopeptidase N. Gastroenterology 106:755-762, 1994
22. Reina J, Salva F, Gil J, Parras F, Alomar P: Biochemical characteristics of Campylobacter pylori strains isolated from gastric biopsies. In Gastroduodenal Pathology and Campylobacter pylori. F Mégraud, H Lamouliatte (eds). Amsterdam, Elsevier Science Publishers, 1989, pp 21-24
23. Kawaguchi M, Saito T, Ohno H, Midorokawa S, Sanji T, Handa Y, Morita S, Yoshida H, Tsurui M, Misaka R, Hirota T, Saito M, Minami K: Bacteria closely resembling Helicobacter pylori detected immunohistologically and genetically in resected gallbladder mucosa. J Gastroenterol 31:294-298, 1996
24. Cetta F: The natural history of gallstones. A reappraisal. Gastroenterology 108(suppl):A412, 1995
25. Cetta F: Bile infection documented as initial event in the pathogenesis of brown pigment biliary stones. Hepatology 6:482-489, 1986
26. Cetta F: The role of bacteria in pigment gallstone disease. Ann Surg 213:315-326, 1991
27. Harvey PRC, Upadhya GA, Strasberg SM: Immunoglobulins as nucleating proteins in the gallbladder bile of patients with cholesterol gallstones. J Biol Chem 266:13996-14003, 1991
28. Clayton CL, Kleanthous H, Coates PJ, Morgan DD, Tabaqchali S: Sensitive detection of Helicobacter pylori by using the polymerase chain reaction. J Clin Microbiol 30:192-200, 1992
29. Cetta F: Bacteria and pathogenesis of gallstones. Gastroenterology 109:2050-2052, 1995
30. Swidsinski A, Ludwig W, Pahlig H, Priem F: Molecular genetic evidence of bacterial colonization of cholesterol gallstones. Gastroenterology 108:860-864, 1995
31. Carey MC, O'Donovan MA: Gallstone disease; current concepts on the epidemiology, pathogenesis, and management. In Harrison's Principles of Internal Medicine - Update V. RG Petersford (ed). New York, McGraw-Hill, 1984, pp 145-183
32. Mégraud F: Epidemiology of Helicobacter pylori infection. In Helicobacter pylori and Gastroduodenal Disease, 2nd ed. BJ Rathbone, RV Heatley (eds). Oxford, Blackwell Scientific Publications, 1992, pp 107-123
33. Jørgensen T, Jensen KH: Eleven-year cumulated incidence of gallstone formation in an unselected Danish population. Gastroenterology 110(suppl):A21, 1996
34. Norrby S, Fagerberg G, Sjödahl R: Decreasing incidence of gallstone disease in a definite Swedish population. Scand J Gastroenterol 21:158-162, 1986
35. von Chaoui Z, Reinbacher L: Cholelithiasis nach Magenresektion? Zbl Chir 107:201-205, 1982
36. Mai UHE, Pérez-Pérez G, Allen JB, Wahl SM, Blaser MJ, Smith PD: Surface protein from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med 175:517-525, 1992
37. Yoshida N, Granger DN, Evans DJ Jr, Evans DG, Graham DY, Anderson DC, Wolf RE, Kvietys PR: Mechanisms involved in Helicobacter pylori-induced inflammation. Gastroenterology 105:1431-1440, 1993
38. Kurose I, Granger DN, Evans DJ Jr, Evans DG, Graham DY, Miyasaka M, Anderson DC, Wolf RE, Cepinskas G, Kvietys PR: Helicobacter pylori-induced microvascular protein leakage in rats: Role of neutrophils, mast cells, and platelets. Gastroenterology 107:70-79, 1994
39. Cetta F: Do surgical and endoscopic sphincterotomy prevent or facilitate recurrent common duct stone formation? Arch Surg 128:329-336, 1993
40. Hornick RB: Enteric fever. In Infections of the Gastrointestinal Tract. MJ Blaser, PD Smith, JI Ravdin, HB Greenberg, RL Guerrant (eds). New York, Raven Press, 1995, pp 325-332
41. Ansorg R, Müller K-D, von Recklinghausen G, Nalik HP: Cholesterol binding of Helicobacter pylori. Zbl Bakteriol 276:323-329, 1992